Detalhe da pesquisa
1.
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
Breast J
; 26(9): 1659-1666, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713113
2.
Characteristics of gastric cancer around the world.
Crit Rev Oncol Hematol
; 181: 103841, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240980
3.
Promoter hypermethylation of RARB and GSTP1 genes in plasma cell-free DNA as breast cancer biomarkers in Peruvian women.
Mol Genet Genomic Med
; 11(12): e2260, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548362
4.
A nationwide pilot study on breast cancer screening in Peru.
Ecancermedicalscience
; 17: 1494, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816782
5.
Sex, immunity, and cancer.
Biochim Biophys Acta Rev Cancer
; 1877(1): 188647, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767966
6.
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077821
7.
Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer.
Ecancermedicalscience
; 16: 1387, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35919233
8.
Chip-based digital Polymerase Chain Reaction as quantitative technique for the detection of PIK3CA mutations in breast cancer patients.
Heliyon
; 8(11): e11396, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36387506
9.
Oncological Care During First Peruvian National Emergency COVID-19 Pandemic: A Multicentric Descriptive Study.
Cancer Manag Res
; 14: 1075-1085, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35300062
10.
Profile of entrectinib in the treatment of ROS1-positive non-small cell lung cancer: Evidence to date.
Hematol Oncol Stem Cell Ther
; 14(3): 192-198, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290717
11.
PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report.
World J Clin Oncol
; 12(8): 702-711, 2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34513603
12.
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
Clin Breast Cancer
; 21(3): 239-246.e4, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221201
13.
Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors.
Front Oncol
; 11: 752918, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737960
14.
ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer.
Crit Rev Oncol Hematol
; 136: 48-55, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30878128
15.
Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America.
Ecancermedicalscience
; 13: 896, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792813
16.
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.
Sci Rep
; 8(1): 4899, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29559701
17.
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
ESMO Open
; 3(3): e000344, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682332
18.
Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.
Mol Genet Genomic Med
; 5(5): 481-494, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28944232
19.
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.
Sci Rep
; 7(1): 1526, 2017 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28484222
20.
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer.
Oncotarget
; 7(15): 20282-92, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958810